ImmunoTek and its subsidiaries manage plasma supply contracts and plasma center development agreements for various pharmaceutical companies: Bayer Pharmaceuticals, Grifols BioTherapeutics S.A., Talecris BioPharma, Octapharma AG, Kedrion BioPharma, LFB Pharmaceuticals, Cangene BioPharma and Emergent Bio Solutions.
We work with a select group of architects and contractors who understand our business thus making the design and build process the most effective and efficient possible. Our standardized approach to collection facility design allows for an average build time of 125 days. ImmunoTek manages relationships with partners that have the capacity to locate, design, and build up to 20 new plasmapheresis centers per year. Per customer requirements, ImmunoTek works as a liaison with a team of architects, contractors, and vendors that have experience building FDA and EU compliant facilities. ImmunoTek will consult with our partners and your firm’s officials about location, layout, design, zoning, specifications, and equipment needed for a healthy start-up.
There are no upcoming events at this time.